ScholarIQanswers from OpenAlex

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

PaperCitations, authors & open-access status

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages have?

ScholarIQcitation count

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages has 1,582 citations in the OpenAlex counts ScholarIQ stores.

When was Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages published?

ScholarIQyear

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages has 2016 year in the ScholarIQ index.

What is the open-access status of Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages?

ScholarIQoa status

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages has bronze oa status in the ScholarIQ index.

What is the DOI of Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages?

ScholarIQdoi

The DOI for Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages is on the source record.

What is the PMID of Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages?

ScholarIQpmid

The PMID for Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages is on the source record.

What is the OpenAlex record for Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages?

ScholarIQopenalex

The OpenAlex for Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial